Loading market data...
15-min delayed
Live
Home Market News Stock Analysis Earnings Penny Stocks Crypto Economy Commodities Learn
Stocks About Contact

Ginkgo Bioworks Holdings, Inc.

DNA XNYS
$9.22 -0.46 (-4.75%) ▼ 15-min delayed
Open
$9.55
High
$9.65
Low
$9.14
Volume
642.2K
Market Cap
$558.64M

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 834 Website →

Key Financials

Period Revenue Net Income EPS
Q3 2025 $38.84M $-80,755,000 $-1.45
Q2 2025 $49.60M $-60,300,000 $-1.10
Q1 2025 $48.32M $-90,957,000 $-1.68
FY 2024 $227.04M $-547,029,000 $-10.54

Get DNA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Ginkgo Bioworks Holdings, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.